Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA ProjectGiordano Madeddu, for the CISAI Group, Elena Ricci et al.|Biomedicine & Pharmacotherapy|2007Cited by 74
Metabolic Syndrome: A Real Threat for HIV-Positive Patients?Paolo Bonfanti, Tiziana Quirino, Elena Ricci et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 29
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)Barbara Menzaghi, Tiziana Quirino, Elena Ricci et al.|Biomedicine & Pharmacotherapy|2012Cited by 17
Reversibility of Central Nervous System Adverse Events in Course of ArtLucia Taramasso, Paolo Bonfanti, Giancarlo Orofino et al.|Viruses|2022Cited by 14
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].Giordano Madeddu, Paolo Bonfanti, Tiziana Quirino et al.|PubMed|2006Cited by 9